Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01076283 · ClinicalTrials.gov registry record · Phase 2
A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking
A Phase 2 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT01076283 is a Phase 2 study that has completed, run by Brown University. The registered enrollment target is 14 participants.
The verdict
NCT01076283, a Phase 2 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
This pilot trial has the goal to demonstrate the feasibility of a study to test the effects of baclofen in a laboratory experiment using cue-reactivity and alcohol-self administration paradigms in non-treatment seeking alcohol-dependent subjects.
Interventions
- DRUG Cyproheptadine
- DRUG Baclofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01076283
The ClinicalTrials.gov registry entry for NCT01076283 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cyproheptadine is the first listed.
NCT01076283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01076283 about?
NCT01076283 is a clinical study titled "A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking". This pilot trial has the goal to demonstrate the feasibility of a study to test the effects of baclofen in a laboratory experiment using cue-reactivity and alcohol-self administration paradigms in non-treatment seeking alcohol-dependent subjects.
What is the current status of trial NCT01076283?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2009-12. Estimated completion is 2010-05.
What interventions are being tested in trial NCT01076283?
The interventions under investigation include: Cyproheptadine (DRUG), Baclofen (DRUG).
Who is sponsoring clinical trial NCT01076283?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.